Utama › Kanser Prostat › Georgia › Atlanta
Kajian klinikal Kanser Prostat di Atlanta, GA
33 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Atlanta (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Mengambil pesertaFasa 3
- Northside Hospital, Atlanta
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- Emory University, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Atlanta VA Medical Center, Decatur · 6 mi jauh
Addressing Health Literacy With a Tailored Survivorship Care Plan
Mengambil peserta
- Grady Memorial Hospital, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Atlanta VA Medical Center, Atlanta
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Mengambil pesertaFasa 4
- Emory University, Atlanta
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Mengambil pesertaFasa 1
- Emory University Winship Cancer Institute, Atlanta
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Mengambil pesertaFasa 1
- Emory Winship Cancer Institute, Atlanta
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Mengambil pesertaFasa 2/3
- Emory University, Atlanta
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Mengambil pesertaFasa 1
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Mengambil pesertaFasa 2
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi jauh
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Mengambil pesertaFasa 2
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi jauh
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Mengambil pesertaFasa 3
- Emory University School of Medicine- Grady Campus ( Site 0103), Atlanta
- Winship Cancer Institute, Emory University ( Site 0003), Atlanta
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Mengambil pesertaFasa 3
- Grady Health System, Atlanta
- Emory Proton Therapy Center, Atlanta
- Emory University Hospital Midtown, Atlanta
- dan 3 lagi
Prostate Active Surveillance Study
Mengambil pesertaKajian pemerhatian
- Emory University, Atlanta
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Mengambil pesertaFasa 1
- Emory University - Winship Cancer Institute, Atlanta
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Mengambil pesertaFasa 1
- Emory University, Atlanta
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Mengambil pesertaFasa 1/2
- Emory University Hospital, Atlanta
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Mengambil pesertaFasa 2
- Winship Cancer Institute, Emory University, Atlanta
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Emory University, Atlanta
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Mengambil pesertaFasa 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- dan 3 lagi
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Mengambil pesertaFasa 2
- Emory University Hospital, Atlanta
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Mengambil pesertaKajian pemerhatian
- Morehouse School of Medicine, Atlanta
- Emory Winship Cancer Institute, Atlanta
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Mengambil pesertaFasa 1/2
- Emory University Hospital, Atlanta
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
Mengambil pesertaFasa 2
- Emory University, Atlanta
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
Mengambil pesertaFasa 3
- Emory Proton Therapy Center, Atlanta
- Winship at Emory Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- dan 1 lagi
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 1/2
- Research Site, Atlanta
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
Mengambil peserta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Improving Health Literacy in African-American Prostate Cancer Patients
Mengambil peserta
- Atlanta VA Medical Center, Atlanta
- Grady Memorial Hospital, Atlanta
- Emory University, Atlanta
- dan 1 lagi
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
Mengambil pesertaFasa 1/2
- Emory University, Atlanta
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Research Site 114, Atlanta
- Research Site 139, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Atlanta
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- dan 2 lagi
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Atlanta
- Kanser (semua jenis)49 kajian
- Kanser Paru-paru Bukan Sel Kecil47 kajian
- Kanser Payudara41 kajian
- Mieloma Pelbagai41 kajian
- Leukemia Mieloid Akut30 kajian
- Kanser Ovari29 kajian
- Kanser Paru-paru29 kajian
- Kanser Kolorektal29 kajian
- Kanser Metastatik28 kajian
- Kegagalan Jantung25 kajian
- Gangguan Depresi Major25 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.